SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,929 | +21.2% | 15,915 | +14.5% | 0.01% | +22.2% |
| Q2 2023 | $1,592 | -11.2% | 13,902 | +6.9% | 0.01% | -10.0% |
| Q1 2023 | $1,792 | +19.2% | 13,002 | +12.1% | 0.01% | +11.1% |
| Q4 2022 | $1,503 | -99.9% | 11,602 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $1,282,000 | +47.4% | 11,602 | 0.0% | 0.01% | +50.0% |
| Q2 2022 | $870,000 | -15.0% | 11,602 | -11.4% | 0.01% | 0.0% |
| Q1 2022 | $1,024,000 | -13.2% | 13,102 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $1,180,000 | -2.6% | 13,102 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $1,212,000 | +18.9% | 13,102 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $1,019,000 | -7.0% | 13,102 | -10.9% | 0.01% | -16.7% |
| Q1 2021 | $1,096,000 | -88.1% | 14,702 | -72.9% | 0.01% | -89.3% |
| Q4 2020 | $9,241,000 | +21.4% | 54,202 | 0.0% | 0.06% | 0.0% |
| Q3 2020 | $7,612,000 | -56.2% | 54,202 | -50.0% | 0.06% | -24.3% |
| Q2 2020 | $17,382,000 | +464.2% | 108,404 | +244.1% | 0.07% | +12.1% |
| Q1 2020 | $3,081,000 | +11.1% | 31,500 | +46.5% | 0.07% | +37.5% |
| Q4 2019 | $2,774,000 | +71.3% | 21,500 | 0.0% | 0.05% | +45.5% |
| Q3 2019 | $1,619,000 | -50.4% | 21,500 | 0.0% | 0.03% | -45.0% |
| Q2 2019 | $3,267,000 | +3.4% | 21,500 | -18.9% | 0.06% | -1.6% |
| Q1 2019 | $3,159,000 | +9.2% | 26,500 | 0.0% | 0.06% | +5.2% |
| Q4 2018 | $2,892,000 | -44.9% | 26,500 | -18.5% | 0.06% | -10.8% |
| Q3 2018 | $5,249,000 | +34.6% | 32,500 | +10.2% | 0.06% | -15.6% |
| Q2 2018 | $3,899,000 | -21.5% | 29,500 | -56.0% | 0.08% | +48.1% |
| Q1 2018 | $4,964,000 | +107.5% | 67,000 | +55.8% | 0.05% | +85.7% |
| Q4 2017 | $2,392,000 | – | 43,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |